If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...
A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...
529 Drug Samples declared NSQ and 55 Spurious in last three calendar years in Rajasthan: Govt in LS (31-03-2025) ...
The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...
This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...
Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes.
Advertisement Advertisement Called Blujepa, the drug works differently than existing antibiotics. It targets two enzymes that ...
The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, ...
The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...
The FDA has approved the drug for use in women and girls over the age of 12 who suffer from uncomplicated urinary tract ...